Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but life-threatening disease resulting from unresolved thromboembolic obstructions. Pulmonary endarterectomy (PEA) surgery is the gold-standard treatment as it is potentially curative; however, not all patients are deemed operable and u...
Main Author: | Marius M. Hoeper |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2015-06-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/24/136/272.full |
Similar Items
-
Medical management of chronic thromboembolic pulmonary hypertension
by: Joanna Pepke-Zaba, et al.
Published: (2017-03-01) -
Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options
by: I. M. Lang
Published: (2009-03-01) -
An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan
by: Henning Gall, et al.
Published: (2017-03-01) -
Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
by: N. H. Kim
Published: (2010-03-01) -
Does combination therapy work in chronic thromboembolic pulmonary hypertension?
by: M.C.J. van Thor, et al.
Published: (2020-08-01)